immuno-oncologynews.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: */xmlrpc.php Disallow: */wp-*.php Disallow: */trackback/ Disallow: *?wptheme= Disallow: *?comments= Disallow: *?replytocom Disallow: */comment-page- Disallow: *?s= Disallow: /feed/ Disallow: /tag/* Disallow: /readme.html Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Immuno-Oncology News Home - Immuno-Oncology |
| Description | Home Categories Immune Checkpoint Inhibitors T cells PD-1 Melanoma Breast Cancer Cancer Vaccines FDA Immuno-Oncology Therapies Approved Drugs Bavencio (Av |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.135.121 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
immuno-oncologynews.com Valuation
|
US$4,616,155
Last updated: 2023-04-28 22:30:36
immuno-oncologynews.com has Semrush global rank of 2,292,883. immuno-oncologynews.com has an estimated worth of US$ 4,616,155, based on its estimated Ads revenue. immuno-oncologynews.com receives approximately 532,634 unique visitors each day. Its web server is located in United States, with IP address 172.67.135.121. According to SiteAdvisor, immuno-oncologynews.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,616,155 |
| Daily Ads Revenue | US$4,262 |
| Monthly Ads Revenue | US$127,832 |
| Yearly Ads Revenue | US$1,533,984 |
| Daily Unique Visitors | 35,509 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| immuno-oncologynews.com. 299 | A | immuno-oncologynews.com. 299 | IP: 172.67.135.121 |
| immuno-oncologynews.com. 299 | A | immuno-oncologynews.com. 299 | IP: 104.21.6.240 |
| immuno-oncologynews.com. 299 | AAAA | immuno-oncologynews.com. 299 | IPV6: 2606:4700:3036::ac43:8779 |
| immuno-oncologynews.com. 299 | AAAA | immuno-oncologynews.com. 299 | IPV6: 2606:4700:3033::6815:6f0 |
| immuno-oncologynews.com. 86400 | NS | immuno-oncologynews.com. 86400 | NS Record: aiden.ns.cloudflare.com. |
| immuno-oncologynews.com. 86400 | NS | immuno-oncologynews.com. 86400 | NS Record: jasmine.ns.cloudflare.com. |
| immuno-oncologynews.com. 300 | MX | immuno-oncologynews.com. 300 | MX Record: 0 aspmx.l.google.com. |
| immuno-oncologynews.com. 300 | TXT | immuno-oncologynews.com. 300 | TXT Record: google-site-verification=dhboYMSIgkpenZLqRcuu2hA1UaXAo9-30gejgfuVIQg |
| immuno-oncologynews.com. 300 | TXT | immuno-oncologynews.com. 300 | TXT Record: v=spf1 mx ip4:104.248.176.213 include:bluehost.com include:sparkpostmail.com ?all |
HtmlToTextCheckTime:2023-04-28 22:30:36
| Home Categories Immune Checkpoint Inhibitors T cells PD-1 Melanoma Breast Cancer Cancer Vaccines FDA Immuno-Oncology Therapies Approved Drugs Bavencio (Avelumab) Imfinzi (Durvalumab) Keytruda (Pembrolizumab) Kymriah (Tisagenlecleucel) Opdivo (Nivolumab) Tecentriq (atezolizumab) Unituxin (Dinutuximab) Yervoy (Ipilimumab) Yescarta (Axicabtagene Ciloleucel) – Formerly KTE-C19 Experimental Therapies a ABBV-181 ABBV-428 ABP798 Actimmune Adagloxad Simolenin ADU-741 (JNJ-64041809 ) ADXS-HER2 ADXS-PSA AE37 AFM11 AFM13 Zalifrelimab (AGEN1884) Balstilimab (AGEN2034) ALKS 4230 AlloStim AM0010 (Pegilodecakin) AMG 211 (MEDI-565) AMG 330 AMG 420 APVO414 (MOR209/ES414) AST-VAC1 ATA520 AutoSynVax b-c Idecaptagene Cicleucel (Ide-Cel; Previously bb2121) BGB324 (bemcentinib) Tislelizumab (Previously BGB-A317) Blincyto (blinatumomab) Biropepimut-S (GL-0817) BMS 986178 BPX-501 BPX-601 BriaVax Canakinumab Cavatak (Coxsackievirus – CVA21) CBT-501 (genolimzumab) CBT-502 Cergutuzumab Amunaleukin CMP-001 |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 21 Oct 2021 21:30:49 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Thu, 21 Oct 2021 22:30:49 GMT
Location: https://immuno-oncologynews.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Cc0ftjaY%2BHZZW8wMlqrdUzYbz0jGBengnlADgDpd9OAiIRB8xlkCWY5FHkre7jw9CEXcANyq72bdjdQ8aLrY8rW0RpSdfmvLN2qMm5QLMm8GtOZqxTa320aIHlwBHDzR8rd%2BwO1M1huKAA%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a1d96d839fc03c8-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Thu, 21 Oct 2021 21:30:49 GMT
content-type: text/html
last-modified: Thu, 21 Oct 2021 20:01:43 GMT
vary: Accept-Encoding
cache-control: no-store, no-cache, must-revalidate
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=POWW17CsjJicUl32PWGqKYJmJVoErbasb9qsak7nx4NgUVLlFzsCPBnKWU3owd0kr%2BqGUqnEnlKKNAU8zmjVik8bDPpLJ0cTY9wz7i8hb8ot2XtmRsMUYVcRVZVPzH39NbsROt4O5fZKqQ%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a1d96d89ea22919-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
immuno-oncologynews.com Whois Information
Domain Name: IMMUNO-ONCOLOGYNEWS.COM Registry Domain ID: 1866321405_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-06-26T15:36:49Z Creation Date: 2014-07-10T16:22:36Z Registry Expiry Date: 2022-07-10T16:22:36Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: AIDEN.NS.CLOUDFLARE.COM Name Server: JASMINE.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T16:30:49Z <<< |